Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 115

1.

The relationship between the systemic inflammatory response, tumour proliferative activity, T-lymphocytic and macrophage infiltration, microvessel density and survival in patients with primary operable breast cancer.

Murri AM, Hilmy M, Bell J, Wilson C, McNicol AM, Lannigan A, Doughty JC, McMillan DC.

Br J Cancer. 2008 Oct 7;99(7):1013-9. doi: 10.1038/sj.bjc.6604667. Epub 2008 Sep 16.

2.

The relationship between components of tumour inflammatory cell infiltrate and clinicopathological factors and survival in patients with primary operable invasive ductal breast cancer.

Mohammed ZM, Going JJ, Edwards J, Elsberger B, Doughty JC, McMillan DC.

Br J Cancer. 2012 Aug 21;107(5):864-73. doi: 10.1038/bjc.2012.347. Epub 2012 Aug 9.

3.

The relationship between lymphocyte subsets and clinico-pathological determinants of survival in patients with primary operable invasive ductal breast cancer.

Mohammed ZM, Going JJ, Edwards J, Elsberger B, McMillan DC.

Br J Cancer. 2013 Sep 17;109(6):1676-84. doi: 10.1038/bjc.2013.493. Epub 2013 Aug 27.

4.

The relationship between tumour necrosis, tumour proliferation, local and systemic inflammation, microvessel density and survival in patients undergoing potentially curative resection of oesophageal adenocarcinoma.

Dutta S, Going JJ, Crumley AB, Mohammed Z, Orange C, Edwards J, Fullarton GM, Horgan PG, McMillan DC.

Br J Cancer. 2012 Feb 14;106(4):702-10. doi: 10.1038/bjc.2011.610. Epub 2012 Jan 12.

5.

Interrelationships between tumor proliferative activity, leucocyte and macrophage infiltration, systemic inflammatory response, and survival in patients selected for potentially curative resection for gastroesophageal cancer.

Crumley AB, Going JJ, Hilmy M, Dutta S, Tannahill C, McKernan M, Edwards J, Stuart RC, McMillan DC.

Ann Surg Oncol. 2011 Sep;18(9):2604-12. doi: 10.1245/s10434-011-1658-7. Epub 2011 Mar 16.

PMID:
21409484
7.

Evaluation of the relationship between the systemic inflammatory response and cancer-specific survival in patients with primary operable breast cancer.

Al Murri AM, Wilson C, Lannigan A, Doughty JC, Angerson WJ, McArdle CS, McMillan DC.

Br J Cancer. 2007 Mar 26;96(6):891-5.

8.
9.

The relationship between the local and systemic inflammatory responses and survival in patients undergoing resection for localized renal cancer.

Lamb GW, McArdle PA, Ramsey S, McNichol AM, Edwards J, Aitchison M, McMillan DC.

BJU Int. 2008 Sep;102(6):756-61. doi: 10.1111/j.1464-410X.2008.07666.x. Epub 2008 Apr 2.

10.

The relationship between the tumour stroma percentage, clinicopathological characteristics and outcome in patients with operable ductal breast cancer.

Gujam FJ, Edwards J, Mohammed ZM, Going JJ, McMillan DC.

Br J Cancer. 2014 Jul 8;111(1):157-65. doi: 10.1038/bjc.2014.279. Epub 2014 May 29.

11.
12.

Breast carcinoma vascularity: a comparison of manual microvessel count and Chalkley count.

Dhakal HP, Bassarova A, Naume B, Synnestvedt M, Borgen E, Kaaresen R, Schlichting E, Wiedswang G, Giercksky KE, Nesland JM.

Histol Histopathol. 2009 Aug;24(8):1049-59.

PMID:
19554512
13.

The relationships between cellular components of the peritumoural inflammatory response, clinicopathological characteristics and survival in patients with primary operable colorectal cancer.

Richards CH, Flegg KM, Roxburgh CS, Going JJ, Mohammed Z, Horgan PG, McMillan DC.

Br J Cancer. 2012 Jun 5;106(12):2010-5. doi: 10.1038/bjc.2012.211. Epub 2012 May 17.

14.

The relationship between lymphovascular invasion and angiogenesis, hormone receptors, cell proliferation and survival in patients with primary operable invasive ductal breast cancer.

Mohammed ZM, McMillan DC, Edwards J, Mallon E, Doughty JC, Orange C, Going JJ.

BMC Clin Pathol. 2013 Nov 25;13(1):31. doi: 10.1186/1472-6890-13-31.

15.

Comparison of the prognostic value of selected markers of the systemic inflammatory response in patients with colorectal cancer.

Leitch EF, Chakrabarti M, Crozier JE, McKee RF, Anderson JH, Horgan PG, McMillan DC.

Br J Cancer. 2007 Nov 5;97(9):1266-70. Epub 2007 Oct 9.

16.

Overview of resistance to systemic therapy in patients with breast cancer.

Gonzalez-Angulo AM, Morales-Vasquez F, Hortobagyi GN.

Adv Exp Med Biol. 2007;608:1-22. Review.

PMID:
17993229
17.

Microvessel density compared with the Chalkley count in a prognostic study of angiogenesis in breast cancer patients.

Hansen S, Sørensen FB, Vach W, Grabau DA, Bak M, Rose C.

Histopathology. 2004 May;44(5):428-36.

PMID:
15139990
18.

Tumor angiogenesis: a new significant and independent prognostic indicator in early-stage breast carcinoma.

Weidner N, Folkman J, Pozza F, Bevilacqua P, Allred EN, Moore DH, Meli S, Gasparini G.

J Natl Cancer Inst. 1992 Dec 16;84(24):1875-87.

PMID:
1281237
19.

Microvessel quantitation in invasive breast cancer by staining for factor VIII-related antigen.

Ogawa Y, Chung YS, Nakata B, Takatsuka S, Maeda K, Sawada T, Kato Y, Yoshikawa K, Sakurai M, Sowa M.

Br J Cancer. 1995 Jun;71(6):1297-301.

20.

Comparison of visual and automated assessment of microvessel density and their impact on outcome in primary operable invasive ductal breast cancer.

Mohammed ZM, Orange C, McMillan DC, Mallon E, Doughty JC, Edwards J, Going JJ.

Hum Pathol. 2013 Aug;44(8):1688-95. doi: 10.1016/j.humpath.2012.11.023. Epub 2013 Apr 8.

PMID:
23574778
Items per page

Supplemental Content

Write to the Help Desk